nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A1—Estropipate—osteoporosis	0.189	0.269	CbGbCtD
Phenoxybenzamine—SLC22A3—Estradiol—osteoporosis	0.153	0.217	CbGbCtD
Phenoxybenzamine—SLC22A2—Estradiol—osteoporosis	0.0904	0.129	CbGbCtD
Phenoxybenzamine—SLC22A1—Estradiol—osteoporosis	0.0785	0.112	CbGbCtD
Phenoxybenzamine—CYP3A4—Calcitriol—osteoporosis	0.0347	0.0494	CbGbCtD
Phenoxybenzamine—CYP3A4—Estropipate—osteoporosis	0.0347	0.0494	CbGbCtD
Phenoxybenzamine—CYP3A4—Ergocalciferol—osteoporosis	0.0278	0.0395	CbGbCtD
Phenoxybenzamine—CYP3A4—Raloxifene—osteoporosis	0.0232	0.033	CbGbCtD
Phenoxybenzamine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0224	0.0319	CbGbCtD
Phenoxybenzamine—CYP3A4—Cholecalciferol—osteoporosis	0.0179	0.0255	CbGbCtD
Phenoxybenzamine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0164	0.0234	CbGbCtD
Phenoxybenzamine—CYP3A4—Estradiol—osteoporosis	0.0144	0.0205	CbGbCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Alendronate—osteoporosis	0.0104	0.144	CcSEcCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Ibandronate—osteoporosis	0.0101	0.14	CcSEcCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Risedronate—osteoporosis	0.00836	0.115	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Estropipate—osteoporosis	0.00227	0.0314	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Alendronate—osteoporosis	0.00224	0.0309	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Ibandronate—osteoporosis	0.00218	0.0301	CcSEcCtD
Phenoxybenzamine—Drowsiness—Calcitriol—osteoporosis	0.00198	0.0274	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Risedronate—osteoporosis	0.0018	0.0248	CcSEcCtD
Phenoxybenzamine—Asthenia—Calcium Acetate—osteoporosis	0.0017	0.0235	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Estradiol—osteoporosis	0.00159	0.022	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Zoledronate—osteoporosis	0.00156	0.0215	CcSEcCtD
Phenoxybenzamine—Asthenia—Ergocalciferol—osteoporosis	0.0015	0.0208	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.0015	0.0207	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Estradiol—osteoporosis	0.0012	0.0166	CcSEcCtD
Phenoxybenzamine—Somnolence—Estropipate—osteoporosis	0.0012	0.0165	CcSEcCtD
Phenoxybenzamine—Fatigue—Estropipate—osteoporosis	0.00116	0.016	CcSEcCtD
Phenoxybenzamine—Somnolence—Calcitriol—osteoporosis	0.00112	0.0155	CcSEcCtD
Phenoxybenzamine—Fatigue—Ibandronate—osteoporosis	0.00111	0.0154	CcSEcCtD
Phenoxybenzamine—Ospemifene—ESR1—osteoporosis	0.00102	0.184	CrCbGaD
Phenoxybenzamine—Tachycardia—Pamidronate—osteoporosis	0.000988	0.0136	CcSEcCtD
Phenoxybenzamine—Asthenia—Estropipate—osteoporosis	0.000967	0.0134	CcSEcCtD
Phenoxybenzamine—Asthenia—Alendronate—osteoporosis	0.000953	0.0132	CcSEcCtD
Phenoxybenzamine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000942	0.013	CcSEcCtD
Phenoxybenzamine—Asthenia—Ibandronate—osteoporosis	0.000927	0.0128	CcSEcCtD
Phenoxybenzamine—Fatigue—Risedronate—osteoporosis	0.000918	0.0127	CcSEcCtD
Phenoxybenzamine—Asthenia—Calcitriol—osteoporosis	0.000908	0.0125	CcSEcCtD
Phenoxybenzamine—Tachycardia—Zoledronate—osteoporosis	0.000903	0.0125	CcSEcCtD
Phenoxybenzamine—Somnolence—Pamidronate—osteoporosis	0.0009	0.0124	CcSEcCtD
Phenoxybenzamine—Fatigue—Pamidronate—osteoporosis	0.000873	0.0121	CcSEcCtD
Phenoxybenzamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000869	0.012	CcSEcCtD
Phenoxybenzamine—Toremifene—ESR1—osteoporosis	0.000829	0.15	CrCbGaD
Phenoxybenzamine—Somnolence—Zoledronate—osteoporosis	0.000822	0.0114	CcSEcCtD
Phenoxybenzamine—Fatigue—Zoledronate—osteoporosis	0.000798	0.011	CcSEcCtD
Phenoxybenzamine—Somnolence—Conjugated Estrogens—osteoporosis	0.000792	0.0109	CcSEcCtD
Phenoxybenzamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000784	0.0108	CcSEcCtD
Phenoxybenzamine—Clomifene—CYP19A1—osteoporosis	0.000778	0.141	CrCbGaD
Phenoxybenzamine—Fatigue—Conjugated Estrogens—osteoporosis	0.000768	0.0106	CcSEcCtD
Phenoxybenzamine—Asthenia—Risedronate—osteoporosis	0.000764	0.0106	CcSEcCtD
Phenoxybenzamine—Asthenia—Pamidronate—osteoporosis	0.000727	0.01	CcSEcCtD
Phenoxybenzamine—Clomifene—ESR1—osteoporosis	0.000716	0.129	CrCbGaD
Phenoxybenzamine—Tachycardia—Estradiol—osteoporosis	0.000696	0.00961	CcSEcCtD
Phenoxybenzamine—Asthenia—Zoledronate—osteoporosis	0.000664	0.00916	CcSEcCtD
Phenoxybenzamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000639	0.00882	CcSEcCtD
Phenoxybenzamine—Somnolence—Estradiol—osteoporosis	0.000634	0.00875	CcSEcCtD
Phenoxybenzamine—Fatigue—Estradiol—osteoporosis	0.000615	0.00849	CcSEcCtD
Phenoxybenzamine—Levomethadyl Acetate—CYP19A1—osteoporosis	0.000608	0.11	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR2—osteoporosis	0.000537	0.0971	CrCbGaD
Phenoxybenzamine—Asthenia—Estradiol—osteoporosis	0.000511	0.00706	CcSEcCtD
Phenoxybenzamine—Tamoxifen—CYP19A1—osteoporosis	0.00036	0.065	CrCbGaD
Phenoxybenzamine—Methadone—CYP19A1—osteoporosis	0.000357	0.0645	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—osteoporosis	0.000331	0.0598	CrCbGaD
Phenoxybenzamine—SLC22A1—Metabolism—GPX1—osteoporosis	1.88e-05	8.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.88e-05	8.54e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—MTHFR—osteoporosis	1.86e-05	8.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FGB—osteoporosis	1.84e-05	8.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FGB—osteoporosis	1.84e-05	8.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PSMA2—osteoporosis	1.84e-05	8.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PSMA5—osteoporosis	1.84e-05	8.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KL—osteoporosis	1.83e-05	8.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	1.83e-05	8.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AGER—osteoporosis	1.83e-05	8.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AGER—osteoporosis	1.83e-05	8.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ADCY5—osteoporosis	1.82e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ADCY5—osteoporosis	1.82e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—IL6—osteoporosis	1.81e-05	8.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—MTHFR—osteoporosis	1.81e-05	8.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	1.79e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CYP19A1—osteoporosis	1.78e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PSMA5—osteoporosis	1.78e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PSMA2—osteoporosis	1.78e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PSMA2—osteoporosis	1.78e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PSMA5—osteoporosis	1.78e-05	8.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	1.76e-05	8.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—IL6—osteoporosis	1.75e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—IL6—osteoporosis	1.75e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	1.75e-05	7.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—ADCY5—osteoporosis	1.74e-05	7.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	7.91e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—MTHFR—osteoporosis	1.73e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CYP19A1—osteoporosis	1.73e-05	7.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CYP19A1—osteoporosis	1.73e-05	7.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CALCA—osteoporosis	1.71e-05	7.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	1.71e-05	7.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KL—osteoporosis	1.7e-05	7.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	1.7e-05	7.75e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—IDH2—osteoporosis	1.69e-05	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—ADCY5—osteoporosis	1.68e-05	7.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—ADCY5—osteoporosis	1.68e-05	7.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.68e-05	7.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TGFB1—osteoporosis	1.67e-05	7.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—LEP—osteoporosis	1.67e-05	7.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	1.66e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CALCA—osteoporosis	1.66e-05	7.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CALCA—osteoporosis	1.66e-05	7.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRS2—osteoporosis	1.65e-05	7.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	1.64e-05	7.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.62e-05	7.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.62e-05	7.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MTHFR—osteoporosis	1.6e-05	7.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.6e-05	7.27e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRS2—osteoporosis	1.6e-05	7.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRS2—osteoporosis	1.6e-05	7.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.59e-05	7.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—GPX1—osteoporosis	1.59e-05	7.24e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.59e-05	7.24e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.59e-05	7.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.57e-05	7.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KL—osteoporosis	1.56e-05	7.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MTHFR—osteoporosis	1.55e-05	7.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MTHFR—osteoporosis	1.55e-05	7.04e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ACP5—osteoporosis	1.54e-05	7.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.54e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TGFB1—osteoporosis	1.52e-05	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IRS2—osteoporosis	1.52e-05	6.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.52e-05	6.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—POMC—osteoporosis	1.52e-05	6.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.51e-05	6.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KL—osteoporosis	1.5e-05	6.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KL—osteoporosis	1.5e-05	6.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.49e-05	6.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—LEP—osteoporosis	1.49e-05	6.77e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—POMC—osteoporosis	1.49e-05	6.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6R—osteoporosis	1.48e-05	6.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TGFB1—osteoporosis	1.47e-05	6.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TGFB1—osteoporosis	1.47e-05	6.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IRS2—osteoporosis	1.47e-05	6.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IRS2—osteoporosis	1.47e-05	6.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.47e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—POMC—osteoporosis	1.47e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—POMC—osteoporosis	1.47e-05	6.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ADCY5—osteoporosis	1.46e-05	6.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—GPX1—osteoporosis	1.45e-05	6.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—POMC—osteoporosis	1.45e-05	6.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IRS1—osteoporosis	1.44e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.44e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	1.44e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.44e-05	6.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.43e-05	6.53e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TPI1—osteoporosis	1.43e-05	6.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6R—osteoporosis	1.43e-05	6.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6R—osteoporosis	1.43e-05	6.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.42e-05	6.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.42e-05	6.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ADCY5—osteoporosis	1.41e-05	6.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ADCY5—osteoporosis	1.41e-05	6.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—LEP—osteoporosis	1.41e-05	6.41e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—GPX1—osteoporosis	1.4e-05	6.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—GPX1—osteoporosis	1.4e-05	6.39e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.4e-05	6.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IRS1—osteoporosis	1.39e-05	6.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IRS1—osteoporosis	1.39e-05	6.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.39e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—POMC—osteoporosis	1.39e-05	6.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.39e-05	6.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.38e-05	6.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6R—osteoporosis	1.35e-05	6.15e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—P4HB—osteoporosis	1.35e-05	6.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.34e-05	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.34e-05	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—MTHFR—osteoporosis	1.34e-05	6.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.34e-05	6.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IRS1—osteoporosis	1.33e-05	6.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.33e-05	6.04e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.32e-05	6.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.32e-05	6.02e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6R—osteoporosis	1.31e-05	5.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6R—osteoporosis	1.31e-05	5.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—MTHFR—osteoporosis	1.3e-05	5.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—MTHFR—osteoporosis	1.3e-05	5.9e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.29e-05	5.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.29e-05	5.88e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.29e-05	5.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IRS1—osteoporosis	1.29e-05	5.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IRS1—osteoporosis	1.29e-05	5.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—POMC—osteoporosis	1.28e-05	5.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.26e-05	5.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.26e-05	5.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.26e-05	5.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6R—osteoporosis	1.25e-05	5.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6R—osteoporosis	1.25e-05	5.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.25e-05	5.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.24e-05	5.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.23e-05	5.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IGF1—osteoporosis	1.23e-05	5.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ADCY5—osteoporosis	1.22e-05	5.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.21e-05	5.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6R—osteoporosis	1.21e-05	5.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6R—osteoporosis	1.21e-05	5.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.19e-05	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.18e-05	5.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SPP1—osteoporosis	1.18e-05	5.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ADCY5—osteoporosis	1.18e-05	5.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ADCY5—osteoporosis	1.18e-05	5.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.18e-05	5.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—POMC—osteoporosis	1.17e-05	5.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.17e-05	5.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.16e-05	5.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.16e-05	5.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.14e-05	5.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.14e-05	5.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SPP1—osteoporosis	1.14e-05	5.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SPP1—osteoporosis	1.14e-05	5.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.1e-05	5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.09e-05	4.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—POMC—osteoporosis	1.07e-05	4.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IRS2—osteoporosis	1.07e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.06e-05	4.81e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.05e-05	4.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—LEP—osteoporosis	1.04e-05	4.75e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ENO1—osteoporosis	1.04e-05	4.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—POMC—osteoporosis	1.04e-05	4.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—POMC—osteoporosis	1.04e-05	4.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—osteoporosis	1.03e-05	4.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IRS2—osteoporosis	1.03e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IRS2—osteoporosis	1.03e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.03e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—osteoporosis	1.03e-05	4.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.03e-05	4.67e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.03e-05	4.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.02e-05	4.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.02e-05	4.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—LEP—osteoporosis	1.01e-05	4.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—LEP—osteoporosis	1.01e-05	4.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—osteoporosis	1e-05	4.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—osteoporosis	1e-05	4.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ESR1—osteoporosis	9.96e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—osteoporosis	9.95e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—osteoporosis	9.95e-06	4.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—POMC—osteoporosis	9.82e-06	4.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ESR1—osteoporosis	9.64e-06	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ESR1—osteoporosis	9.64e-06	4.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	9.58e-06	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	9.52e-06	4.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	9.45e-06	4.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—osteoporosis	9.4e-06	4.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IRS1—osteoporosis	9.31e-06	4.24e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IRS1—osteoporosis	9e-06	4.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IRS1—osteoporosis	9e-06	4.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—POMC—osteoporosis	8.96e-06	4.08e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	8.9e-06	4.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	8.76e-06	3.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6R—osteoporosis	8.74e-06	3.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—POMC—osteoporosis	8.67e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—POMC—osteoporosis	8.67e-06	3.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—osteoporosis	8.62e-06	3.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6R—osteoporosis	8.46e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6R—osteoporosis	8.46e-06	3.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—osteoporosis	8.34e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—osteoporosis	8.34e-06	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.33e-06	3.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MYC—osteoporosis	8.29e-06	3.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	8.27e-06	3.76e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	7.78e-06	3.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—osteoporosis	7.48e-06	3.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	7.47e-06	3.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—osteoporosis	7.4e-06	3.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—osteoporosis	7.39e-06	3.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—osteoporosis	7.38e-06	3.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	7.37e-06	3.35e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	7.23e-06	3.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—osteoporosis	7.16e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—osteoporosis	7.16e-06	3.26e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—osteoporosis	7.14e-06	3.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—osteoporosis	7.14e-06	3.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—osteoporosis	6.99e-06	3.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	6.97e-06	3.17e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—osteoporosis	6.88e-06	3.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	6.86e-06	3.12e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.8e-06	3.1e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—osteoporosis	6.78e-06	3.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—osteoporosis	6.59e-06	3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—osteoporosis	6.38e-06	2.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—osteoporosis	6.38e-06	2.9e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.26e-06	2.85e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—osteoporosis	6.23e-06	2.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.11e-06	2.78e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.1e-06	2.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—osteoporosis	6.02e-06	2.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—osteoporosis	5.83e-06	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—osteoporosis	5.83e-06	2.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—osteoporosis	5.68e-06	2.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	5.66e-06	2.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—osteoporosis	5.63e-06	2.56e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—osteoporosis	5.56e-06	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—osteoporosis	5.55e-06	2.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—osteoporosis	5.38e-06	2.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—osteoporosis	5.38e-06	2.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—osteoporosis	5.26e-06	2.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—osteoporosis	5.18e-06	2.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—osteoporosis	5.17e-06	2.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—osteoporosis	5.17e-06	2.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—osteoporosis	5.01e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—osteoporosis	5.01e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—POMC—osteoporosis	5.01e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—osteoporosis	5e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—osteoporosis	5e-06	2.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—osteoporosis	4.59e-06	2.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—osteoporosis	4.27e-06	1.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—osteoporosis	3.89e-06	1.77e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—osteoporosis	3.77e-06	1.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—osteoporosis	3.77e-06	1.71e-05	CbGpPWpGaD
